Purification of High Yield Extracellular Vesicle Preparations Away from Virus
September 12th, 2019
11.7K views
This protocol isolates extracellular vesicles (EVs) away from virions with high efficiency and yield by incorporating EV precipitation, density gradient ultracentrifugation, and particle capture to allow for a streamlined workflow and a reduction of starting volume requirements, resulting in reproducible preparations for use in all EV research.
Overview
This protocol is significant because it concentrates extracellular vesicles (EVs) through a combination of technologies, allowing for the separation of virions away from EVs. It maximizes EV recovery above the current gold standard of ultracentrifugation, making it ideal for the study of EVs and viral infections.
Key Study Components
Area of Science
- Extracellular vesicles
- Viral infections
- Biological protocols
Background
- This method incorporates EV precipitation, density gradient ultracentrifugation, and particle capture.
- It allows for a streamlined workflow and a reduction of starting volume requirements.
- Reproducible preparations are essential for all EV research.
- The protocol can be adapted to other virus systems, such as HTLV, Ebola, and Zika.
Purpose of Study
- To isolate extracellular vesicles with high efficiency and yield.
- To provide a method for virus-free EV preparations.
- To facilitate multiple downstream analysis and characterization of EVs.
Methods Used
- EV precipitation
- Density gradient ultracentrifugation
- Particle capture techniques
- Optimization of nanoparticle preparation
Main Results
- High efficiency in isolating EVs from virions.
- Improved recovery rates compared to traditional methods.
- Adaptability to various viral systems.
- Potential challenges for first-time users in nanoparticle preparation.
Conclusions
- This protocol offers a reliable method for studying EVs in the context of viral infections.
- It sets a new standard for EV isolation techniques.
- Careful adherence to specifications is recommended for optimal results.
Frequently Asked Questions
What are extracellular vesicles?
Extracellular vesicles (EVs) are membrane-bound particles released by cells that play a role in cell communication.
How does this protocol improve EV isolation?
This protocol combines multiple technologies to enhance the efficiency and yield of EV isolation compared to traditional methods.
Can this method be used for different viruses?
Yes, the protocol can be adapted for various viruses, including HTLV, Ebola, and Zika.
What challenges might a first-time user face?
First-time users may struggle with nanoparticle preparation, so following the specifications closely is advised.
What is the significance of separating virions from EVs?
Separating virions from EVs is crucial for obtaining pure EV preparations for accurate analysis and characterization.
Is optimization necessary for this protocol?
Some optimization may be necessary depending on the specific system being used.
Executive Industry Relevance
Isolating virus-free extracellular vesicles (EVs) is critical for mechanistic studies in viral pathogenesis and therapeutic development. This method enables high-yield, purified EV preparations from infected cultures, reducing viral contamination and improving data reliability for downstream functional assays. It supports early discovery workflows by providing scalable, reproducible inputs for target validation and biomarker screening in virology-focused research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of EV-mediated mechanisms in viral infection by isolating EVs away from virions.
- Operational Value: Reduces starting volume requirements compared to ultracentrifugation, increasing throughput in early-stage screening.
Screening & Assay Development
- Scientific Value: Produces virus-free EV preparations suitable for Western blot, PCR, and mass spectrometry-based functional characterization.
- Operational Value: Streamlines workflow with precipitation, density gradient, and particle capture steps, minimizing hands-on time and technical variability.
Translational & Preclinical Research
- Scientific Value: Supports studies of EV cargo and functionality in HIV-1 and other viral systems without confounding viral background.
- Operational Value: Adaptable to HTLV, Ebola, Zika, and other viruses, enabling cross-project reuse in antiviral research programs.
Pipeline & Workflow Integration
This method fits within the discovery continuum by providing purified EV inputs for mechanistic de-risking and target validation in viral infection models.
- Discovery Biology: Enables hypothesis testing of EV roles in pathogenesis by removing viral contaminants that confound interpretation.
- Screening: Delivers standardized, quantifiable EV outputs compatible with downstream analytical platforms for compound or modulator screening.
- Analytics: Yields enriched EV fractions suitable for Western blot, PCR, and mass spectrometry, enabling comparative analysis across conditions.
- Translational Research: Facilitates continuity from discovery to preclinical studies by providing virus-free EVs for functional mechanism investigation.
- Enterprise Reuse: Establishes a scalable, adaptable protocol for EV isolation across multiple viral systems, reducing redundant method development.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in EV functional studies by eliminating viral contamination artifacts.
- Operational Value: Improves reproducibility and yield over conventional ultracentrifugation, reducing batch failure rates.
- Strategic Value: Supports better go/no-go decisions in target validation by providing cleaner mechanistic data.
- Portfolio Impact: Enables risk-adjusted prioritization of EV-based biomarkers or therapeutic leads in viral disease areas.
Implementation Considerations
- Requires expertise in ultracentrifugation and nanoparticle handling for optimal EV enrichment.
- Dependent on access to swinging bucket ultracentrifuge and iodixanol gradient preparation capabilities.
- Necessitates standardization of nanoparticle slurry preparation across users and labs.
- Limited by difficulty in eluting intact EVs from nanoparticles, restricting functional assays requiring native vesicles.
- Best suited for research-scale applications; not designed for GMP or commercial manufacturing.
Biopharma FAQs
Why is separating virions from EVs important for target validation?
Separating virions from EVs is essential to obtain pure extracellular vesicle preparations, ensuring that observed functional effects are attributable to EVs and not contaminating virus. This improves data accuracy in mechanistic studies and reduces false positives in target validation assays.
How does nanoparticle addition improve EV recovery after density gradient separation?
The addition of a nanoparticle slurry (NT80, NT82, and PBS) following density gradient centrifugation concentrates EVs through affinity-based capture, significantly increasing yield. Without this step, EV recovery is poor due to low particle concentration in gradient fractions.
What quantitative measurements enable assessment of EV isolation efficiency?
EV isolation efficiency is assessed through Western blot analysis of exosome markers such as CD81, CD63, and CD9, with reported increases of 3000-fold, 4-fold, and 40-fold respectively over ultracentrifugation. These measurements provide quantifiable benchmarks for yield and purity.
Why are replication requirements critical for cross-functional collaboration in EV workflows?
Replication ensures consistent EV yield and purity across users and labs, which is essential for sharing standardized preparations between discovery, screening, and translational teams. The protocol emphasizes careful adherence to specifications to minimize variability.
What statistical analysis capabilities are required before implementing this EV isolation method?
Implementation requires the ability to quantify EV markers via Western blot or comparable assays to compare recovery and purity against controls. Statistical evaluation of replicate preparations is necessary to assess method robustness and yield improvements.
Chapters in this video
0:04
Title
1:00
Filtration and Precipitation of Extracellular Vesicles
2:25
Construction of a Density Gradient and Enrichment of EV Fractions
4:06
Preparation of Nanoparticle Pellet for Downstream Assay
5:05
Results: Increased EV Yield and Characterization of EVs
6:09
Conclusion
